Journals / Eurasian Journal of Medicine / 2013 / Cilt: 45 - Sayı: 2

Türkiye’de balon ile açılan trans kateter aort kapak yerleştirmesinde genç kardiyologların ilk deneyimleri

Initial experiences of young cardiologists with balloon-expandable transcatheter aortic valve implantation in Turkey: A case series of eleven patients

Pages
99–107
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Intrap- rocedural mortality was not observed, and the overall 3 month mortality was 9%.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Surgical aortic valve replacement is the gold standard oftreatment for symptomatic severe aortic stenosis in all age groups.Transcatheter aortic valve implantation (TAVI), which is performed bysenior interventional cardiologists in experienced centers, is an alternative therapy for patients considered to be at high risk for surgery.The aim of this study is to describe the procedural success and shortterm results of TAVI performed by young interventional cardiologistsin Trabzon, Turkey.Materials and Methods: Eleven patients, 10 women and 1 man, who were treated by balloon-expandable TAVI through transfemoral access between January 2012 and April 2012, were included in the study.
📊
Key Findings & Data:Results: The median calculated logistic EuroSCORE and Society of Thoracic Surgeons (STS) score of patients were 28% (24%-34%) and 14% (12%-18%), respectively.
💡
Conclusion & Impact:Intrap- rocedural mortality was not observed, and the overall 3 month mortality was 9%.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Surgical aortic valve replacement is the gold standard oftreatment for symptomatic severe aortic stenosis in all age groups.Transcatheter aortic valve implantation (TAVI), which is performed bysenior interventional cardiologists in experienced centers, is an alternative therapy for patients considered to be at high risk for surgery.The aim of this study is to describe the procedural success and shortterm results of TAVI performed by young interventional cardiologistsin Trabzon, Turkey.Materials and Methods: Eleven patients, 10 women and 1 man, who were treated by balloon-expandable TAVI through transfemoral access between January 2012 and April 2012, were included in the study. The clinical and echocardiographic parameters of the patients were compared before and three months after the procedure. Results: The median calculated logistic EuroSCORE and Society of Thoracic Surgeons (STS) score of patients were 28% (24%-34%) and 14% (12%-18%), respectively. The median age of the patients was 83 years and ranged from 80-85 years. The mean aortic valve pres- sure gradient and the aortic valve area were significantly improved after TAVI. The mean aortic valve pressure gradient was 48 (46-53) mmHg before treatment and 20 (16-23) mmHg after treatment (p=0.003). The aortic valve area was 0.65 (0.55-0.70) cm2 before treatment and 1.7 (1.6-1.8) cm2 after treatment. The functional status of the patients improved from NYHA class 3-4 to NYHA class 1-2. Intrap- rocedural mortality was not observed, and the overall 3 month mortality was 9%. Conclusion: TAVI can be performed successfully by young cardiologists. In centers with high patient loads, we encourage young cardiologists to perform TAVI if they have received the appropriate training and to form specialized, cooperating teams with a focus on TAVI.

Özet

Amaç: Gelişmiş ülkelerde artan yaşam beklentisine bağlı olarak kalsifik aort darlığı en sık görülen kalp kapağı hastalığıdır. Cerrahi kapak ameliyatı semptomatik, ileri aort darlığı tedavisininde tüm yaşgruplarında altın standart tedavidir. Cerrahi için yüksek riskli Kabuledilen hastalarda trans kateter aort kapak yerleştirilmesi (TAKY) al-ternatif bir tedavi seçeneğidir. TAKY deneyimli merkezlerde kıdemli girişimsel kardiyologlar tarafından yapılmaktadır. Bu çalışmada gençkardiyologlar tarafından yapılan TAKY’nin işlem başarısı ve kısa dö- nem sonuçlarının değerlendirilmesi amaçlandı. Gereç ve Yöntem: Ocak 2012 ile Nisan 2012 tarihleri arasında balon ile açılan TAKY işlemi uygulanan 11 hasta (1 erkek) çalışmaya dahil edildi. Hastaların işlem öncesi ve işlemden 3 ay sonraki klinik ve ekokardiyografik verileri incelendi. Bulgular: Hastaların ortalam yaşı, hesaplanmış EuroSCORE ve STS skorları sırasıyla 89.8±3.4 yıl, %28.4±5.4 ve %14.9±2.9 olarak bulundu. Ortalama aort kapak basıncı ve aortk kapak alanı işlem sonrası anlamlı olarak düzeldi (sırasıyla 49.8±5.9 mmHg to 20.5±3.6 p=0.003 ve 0.66±0.08 cm2 ‘den 1.7±0.1 p=0.003). Hastaların fonksiyonel kapasiteleri NYHA class 3-4 den NYHA class 1-2 ye arttı. İşlem sırasında mortalite görülmedi, üçlük aylık toplam mortalite ise %9’dur. Sonuç: TAKY pahalı ve çok komplike bir işlem olduğu için iyi eğitilmiş ve kopere ekipler tarafından yüksek hasta sayılı merkezlerde yapıl- malıdır.

🔖

Cite This Article

DOGAN, O. V., PARLAR, A. I., CELİK, S., AGAC, M. T., GOKDENİZ, T., AYKAN, A. C. (2022). Türkiye’de balon ile açılan trans kateter aort kapak yerleştirmesinde genç kardiyologların ilk deneyimleri. Eurasian Journal of Medicine, Cilt: 45 - Sayı: 2, 99–107. https://ajindex.com/articles/509191

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Iung B, Baron G, Butchart EG, Delahaye F, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24: 1231-43. [CrossRef] 2. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368: 1005-11. [CrossRef] 3. Bonow RO, Carabello BA, Chatterjee K, et al. 2006 Writing Committee Members; American College of Cardiology/ American Heart Association Task Force. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 7; 118:523-661. 4. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcath- eter implantation of aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106: 3006-8. [CrossRef] 5. Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percu- taneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004; 43: 698-703. [CrossRef] 6. Lefèvre T, Kappetein AP, Wolner E, et al. PARTNER EU Investigator Group. One year follow-up of the multi-Centre European PARTNER transcatheter heart valve study. Eur Heart J 2011; 32: 148-57. [CrossRef] 7. Thomas M, Schymik G, Walther T, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of trans- catheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011; 124: 425-33. [CrossRef] 8. Roques F, Nashef SA, Michel P, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999; 15: 816-23. [CrossRef] 9. O’Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg 2009; 88: 23-42. [CrossRef] 10. Yücel G, Paker T, Akçevin A, et al. Transcatheter aortic valve implantatio